期刊文献+

阿司匹林在冠心病二级预防中的应用现况 被引量:23

The present status of the use of aspirin for secondary prevention of coronary artery disease
原文传递
导出
摘要 目的了解中国多省市冠心病患者阿司匹林应用现况。方法以2781例既往曾确诊患有冠心病的门诊患者为研究对象。2006年在中国内地31个省市自治区选择32家三级医院和32家二级医院,每家医院以研究启动时点起连续选择既往曾确诊冠心病的门诊患者50例。采用访谈形式收集患者信息,填写统一表格。主要分析患者阿司匹林的应用及医生处方情况。结果(1)在2781例门诊冠心病患者中,男性1914例,女性867例,年龄(65±10)岁;(2)门诊冠心病患者阿司匹林的服用率为83.6%,男性(85.1%)高于女性(80.4%,P〈0.01),随着年龄的增加,阿司匹林的服用率呈下降趋势(P〈0.05),不同省市协作医院间阿司匹林的服用率存在差异(P〈0.01),其中贵州省患者阿司匹林的服用率最低(64.2%),浙江省最高(97.8%);(3)门诊冠心病患者阿司匹林的处方率为90.4%,总计93.0%的医生处方剂量符合《阿司匹林在动脉硬化性心血管疾病中临床应用:中国专家共识(2005)》中建议使用的剂量(75~150mg/d),不同省市协作医院医生处方剂量存在差异,个别医院1/3的处方剂量低于75mg/d;(4)女性、高龄、月收入低、既往无经皮冠状动脉介入治疗史及冠心病病程长的门诊冠心病患者,阿司匹林的服用率低。结论我国内地门诊冠心病患者阿司匹林的总服用率为83.6%,但31个省市、64家医院间差异较大;各医院医生阿司匹林处方剂量间也存在很大差异,应在冠心病二级预防中引起足够重视。 Objective To examine the current status of the use of aspirin among outpatients with established coronary heart disease (CHD) in China. Methods Sixty-four hospitals across 31 provinces of China, including 32 secondary hospitals and 32 tertiary hospitals were selected for a baseline survey. Fifty outpatients with history of acute coronary syndrome (ACS) were recruited consecutively in each hospital. Information of these patients was collected and the situation of aspirin use among the patients was analyzed. Results There totally 2781 CHD outpatients were recruited with complete data. Mean age of the patients was 65±10. Sixty-nine percent of the patients was males and 31% was females. The utilization rate of aspirin before this clinical visit was 83.6%. There were significant difference among regions and hospitals. The utilization rate of aspirin was 64. 2% and 97.8% respectively in the two provinces with the lowest use rate and the highest use rate. Use rates of aspirin in CHD outpatients varied from 29.4% to 98% among 64 hospitals. The male CHD patients had higher use rate than the female patients did (85.1% vs. 80. 4% , P 〈0. 01 ). There also was notable difference in prescribed dose of aspirin among regions and hospitals. An analysis of multiple logistic regression model revealed that gender, age, monthly income, history of PCI and onset time of the previous ACS event were independently associated with the utilization status of aspirin in these outpatients. Conclusions The overall utilization rate of aspirin in CHD outpatients reached to 83.6%, but remarkable differences in aspirin use existed among regions, hospitals and patients with different characteristics in current clinical practice in China.
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第10期809-813,共5页 Chinese Journal of Internal Medicine
基金 感谢辉瑞制药有限公司对本项目的大力赞助
关键词 冠状动脉疾病 阿司匹林 处方 药物 Coronary artery disease Aspirin Prescriptions,drug
  • 相关文献

参考文献3

二级参考文献50

  • 1Antithrombotic trialists'collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ,2002,324:71-86.
  • 2Bertrand ME, Simoons ML, Fox KAA,et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The task force of the management of acute coronary syndromes of the European Society of Cardiology. Eur Heart J,2002,23:1809-1840.
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on practice Guidelines (Committee on the Management of Patients With Unstable Angina).J Am Coll Cardiol, 2000,36:970-1062.
  • 4ETDRS investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 14. JAMA,1992,268:1292-1300.
  • 5Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:principal results of the Hypertension Optimal Treatment (HOT)ranomised trial. Lancet,1998,351:1755-1762.
  • 6Frilling B, Schiele R, Gitt AK, et al. Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: Results from the MITRA and MIR studies. Am Heart J ,2001,141:200-205.
  • 7Sleeper RB, Rojas-Fernandez C.Underutilization of aspirin for secondary prophylaxis of cardiovasucular disease in a long-term-care facility. Am J Health-syst Pharm,2002,59:1294-1295.
  • 8Patrono C, Bachmann F, Baigent C, et al. Expert Consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. Eur Heart J ,2004,25:166-181.
  • 9Montague TJ, Wong RY, Burton JR, et al. Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-1990. Can J Cardiol, 1992,8:596-600.
  • 10Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med,1996,124:292-298.

共引文献219

同被引文献165

引证文献23

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部